Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin
International Journal of Health Policy and Management · 20.09.2023 · 12 · 7724
DOI: 10.34172/ijhpm.2023.7724 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Policy and Management, online erschienen am 20.09.2023. Verfasst von Boya Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. Hauptthemen laut MEDLINE: Health Expenditures, Drugs, Generic. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
National Volume-Based Procurement (NVBP) program has been carried out in China to lower drug prices and reduce patients’ medication burden. This study aims to evaluate its impact on drug purchasing in Tianjin city, one of the first 11 cities piloting NVBP in China.
Methods
Using monthly drug procurement data from Tianjin Medical Purchasing Center between 2018 and 2020, this study identified bid-winning drugs and their alternative drugs in the pilot NVBP, and evaluated the policy impacts on their procurement price (cost of defined daily dose, DDDc), volume (the number of defined daily dose, DDDs), and expenditure, during the first (initiated at April 1, 2019) and second (initiated at April 25, 2020) procurement cycles of pilot NVBP, applying interrupted time series (ITS) analysis. Included drugs were classified into 12 pharmacological subgroups for further analysis.
Results
Decrease in DDDc of NVBP-covered drugs (bid-winning and non-winning drugs) were observed in the first (level change: -CNY 3.878/DDD, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
- Center for Social Science Survey and Data, Tianjin University, Tianjin, China.
Zitieren
APA
Zhao, B., & Wu, J. (2023). Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin. International Journal of Health Policy and Management, 12, 7724. https://doi.org/10.34172/ijhpm.2023.7724
Vancouver
Zhao B, Wu J. Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin. International Journal of Health Policy and Management. 2023;12:7724. doi:10.34172/ijhpm.2023.7724
BibTeX
@article{Zhao2023,
author = {Zhao, Boya and Wu, Jing},
title = {Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin},
journal = {International Journal of Health Policy and Management},
year = {2023},
volume = {12},
pages = {7724},
doi = {10.34172/ijhpm.2023.7724}
}
EUVIMED